Full coverage: Pharmaceuticals

Through a series of mergers and demergers in the last decade, a global pharmaceutical manufacturer became Irish. To defend itself against a Vat claim, it had to reveal the details of the scheme.

Exchequer returns showed swings of hundreds of millions of euros between 2020 and 2021 following a dispute on emergency stamp duty rules. The exact details of the settlement reached between AbbVie and the tax authority, however, remain secret.

Mallinckrodt, a 155-year-old US pharmaceutical manufacturer, came to Ireland in 2013 to set up an intricate corporate and tax structure. After thousands of legal actions threatened to shut it down, its salvage deal has just cleared an Irish examinership.

Perigord, which designs artwork for the life sciences sector, sold a majority stake to Indian giant Tech Mahindra last year for €21 million. It has brought fire power and even more ambition to the business, says Perigord CEO Alan Leamy.

Successive rule changes purported to outlaw the double Irish and single malt tax structures but they left a gap wide open. Here is how Abbott stepped into it to minimise the tax due on profits from Covid-19 and other medical tests.

Months before Covid-19, Abbott Laboratories completed the reorganisation of a rapid diagnostics unit across Ireland and Malta. When this business ballooned, profits trickled through the supposedly closed double Irish loophole.

McKesson Ireland is sale agreed to Phoenix, a German pharmaceutical group controlled by the billionaire Merckle family. Its final set of Irish accounts shows what the Germans are actually buying.

A New York-listed pharmaceutical multinational is seeking approval from US courts to emerge from a crushing pile of debt and litigation. The next steps will play out in the High Court in Dublin, where the firm is formally registered and owns billions of dollars' worth of intellectual property.

The Irish tax authority has forced settlements from 600 contract workers at pharma and IT giants for overstating their travel and business expenses. Drawing from documents obtained under FOI, new data and legal filings, this is the story of Revenue’s 10-year contractor probe.

The Irish tax authority has initiated a legal action against Novartis, a Swiss pharmaceutical multinational with major operations in Ireland. But why is Revenue targeting the company, and how much is at stake?